Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORMD-0801 in Type 2 Diabetes Mellitus
NCT02954601Phase 2Completed
- Sponsor
- Oramed Pharmaceuticals Inc.
- Start
- Oct 2016
- Primary completion
- Feb 2017
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of ORMD-0801 in type 2 diabetes mellitus (T2DM), sponsored by Oramed Pharmaceuticals Inc.. Started Oct 2016; status: completed.
02
Drugs
ORMD-0801
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02954601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02954601.